193 related articles for article (PubMed ID: 22414702)
1. Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation.
Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
Eur J Pharm Sci; 2012 Aug; 46(5):374-80. PubMed ID: 22414702
[TBL] [Abstract][Full Text] [Related]
2. Design and evaluation of inhalable chitosan-modified poly (DL-lactic-co-glycolic acid) nanocomposite particles.
Yang M; Yamamoto H; Kurashima H; Takeuchi H; Yokoyama T; Tsujimoto H; Kawashima Y
Eur J Pharm Sci; 2012 Aug; 47(1):235-43. PubMed ID: 22683651
[TBL] [Abstract][Full Text] [Related]
3. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.
Yamamoto H; Kuno Y; Sugimoto S; Takeuchi H; Kawashima Y
J Control Release; 2005 Feb; 102(2):373-81. PubMed ID: 15653158
[TBL] [Abstract][Full Text] [Related]
4. Preparation and in vitro-in vivo evaluation of salmon calcitonin-loaded polymeric nanoparticles.
Glowka E; Sapin-Minet A; Leroy P; Lulek J; Maincent P
J Microencapsul; 2010; 27(1):25-36. PubMed ID: 19229671
[TBL] [Abstract][Full Text] [Related]
5. Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting.
Nasr M; Awad GA; Mansour S; Taha I; Al Shamy A; Mortada ND
Eur J Pharm Biopharm; 2011 Nov; 79(3):601-11. PubMed ID: 21827854
[TBL] [Abstract][Full Text] [Related]
6. Encapsulation into PEG-liposomes does not improve the bioavailability of pulmonary delivered salmon calcitonin.
Swaminathan J; Gobbo OL; Tewes F; Healy AM; Ehrhardt C
J Aerosol Med Pulm Drug Deliv; 2014 Feb; 27(1):1-11. PubMed ID: 24252061
[TBL] [Abstract][Full Text] [Related]
7. Preparation and in vitro evaluation of etoposide-loaded PLGA microspheres for pulmonary drug delivery.
Feng R; Zhang Z; Li Z; Huang G
Drug Deliv; 2014 May; 21(3):185-92. PubMed ID: 24107001
[TBL] [Abstract][Full Text] [Related]
8. Design and Characterizations of Inhalable Poly(lactic-
Sato H; Tabata A; Moritani T; Morinaga T; Mizumoto T; Seto Y; Onoue S
Molecules; 2020 Mar; 25(6):. PubMed ID: 32183032
[TBL] [Abstract][Full Text] [Related]
9. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation.
Cetin M; Aktas MS; Vural I; Ozturk M
J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314
[TBL] [Abstract][Full Text] [Related]
10. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
[TBL] [Abstract][Full Text] [Related]
11. Preparation and in vivo absorption evaluation of spray dried powders containing salmon calcitonin loaded chitosan nanoparticles for pulmonary delivery.
Sinsuebpol C; Chatchawalsaisin J; Kulvanich P
Drug Des Devel Ther; 2013; 7():861-73. PubMed ID: 24039397
[TBL] [Abstract][Full Text] [Related]
12. Preparation and properties of inhalable nanocomposite particles for treatment of lung cancer.
Tomoda K; Ohkoshi T; Hirota K; Sonavane GS; Nakajima T; Terada H; Komuro M; Kitazato K; Makino K
Colloids Surf B Biointerfaces; 2009 Jul; 71(2):177-82. PubMed ID: 19264458
[TBL] [Abstract][Full Text] [Related]
13. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells.
Tahara K; Sakai T; Yamamoto H; Takeuchi H; Hirashima N; Kawashima Y
Int J Pharm; 2009 Dec; 382(1-2):198-204. PubMed ID: 19646519
[TBL] [Abstract][Full Text] [Related]
14. Spray-drying preparation of microparticles containing cationic PLGA nanospheres as gene carriers for avoiding aggregation of nanospheres.
Takashima Y; Saito R; Nakajima A; Oda M; Kimura A; Kanazawa T; Okada H
Int J Pharm; 2007 Oct; 343(1-2):262-9. PubMed ID: 17628365
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo characterisation of PEG-lipid-based micellar complexes of salmon calcitonin for pulmonary delivery.
Baginski L; Gobbo OL; Tewes F; Salomon JJ; Healy AM; Bakowsky U; Ehrhardt C
Pharm Res; 2012 Jun; 29(6):1425-34. PubMed ID: 22322897
[TBL] [Abstract][Full Text] [Related]
16. Formulation, characterization and evaluation of cyclodextrin-complexed bendamustine-encapsulated PLGA nanospheres for sustained delivery in cancer treatment.
Gidwani B; Vyas A
Pharm Dev Technol; 2016 Mar; 21(2):161-71. PubMed ID: 25391288
[TBL] [Abstract][Full Text] [Related]
17. One-step preparation of rifampicin/poly(lactic-co-glycolic acid) nanoparticle-containing mannitol microspheres using a four-fluid nozzle spray drier for inhalation therapy of tuberculosis.
Ohashi K; Kabasawa T; Ozeki T; Okada H
J Control Release; 2009 Apr; 135(1):19-24. PubMed ID: 19121349
[TBL] [Abstract][Full Text] [Related]
18. Preparation and evaluation of biodegradable films containing the potent osteogenic compound BFB0261 for localized delivery.
Umeki N; Sato T; Harada M; Takeda J; Saito S; Iwao Y; Itai S
Int J Pharm; 2011 Feb; 404(1-2):10-8. PubMed ID: 21047548
[TBL] [Abstract][Full Text] [Related]
19. Histological examination of PLGA nanospheres for intratracheal drug administration.
Hara K; Tsujimoto H; Tsukada Y; Huang CC; Kawashima Y; Tsutsumi M
Int J Pharm; 2008 May; 356(1-2):267-73. PubMed ID: 18276091
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sorafenib-loaded poly (lactic/glycolic) acid and DPPC liposome nanoparticles in the in vitro treatment of renal cell carcinoma.
Liu J; Boonkaew B; Arora J; Mandava SH; Maddox MM; Chava S; Callaghan C; He J; Dash S; John VT; Lee BR
J Pharm Sci; 2015 Mar; 104(3):1187-96. PubMed ID: 25573425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
